Highlights and Quick Summary
- Average Common Equity for the quarter ending May 31, 2022 was $409 Million (a 33.33% increase compared to previous quarter)
- Year-over-year quarterly Average Common Equity increased by 35.6%
- Annual Average Common Equity for 2021 was $305 Million (a 28.43% increase from previous year)
- Annual Average Common Equity for 2020 was $237 Million (a 22.34% increase from previous year)
- Annual Average Common Equity for 2019 was $194 Million (a 87.04% increase from previous year)
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Average Common Equity of Organigram Holdings Inc.
Most recent Average Common Equityof OGI including historical data for past 10 years.Interactive Chart of Average Common Equity of Organigram Holdings Inc.
Organigram Holdings Inc. Average Common Equity for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $409.25 | $306.95 | – | – | – |
| 2021 | $309.56 | $301.81 | $322.48 | $248.34 | $304.72 |
| 2020 | $245.37 | $234.74 | $240.02 | $247.41 | $237.26 |
| 2019 | $213.4 | $195.61 | $240.02 | $247.41 | $193.93 |
| 2018 | – | – | $213.4 | $195.61 | $103.69 |
| 2017 | – | – | – | – | $49.58 |
| 2016 | – | – | – | – | $49.58 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic